- Report
- January 2026
- 550 Pages
Global
From €4402EUR$5,000USD£3,804GBP
- Report
- July 2025
- 350 Pages
Global
From €4357EUR$4,949USD£3,766GBP
- Report
- June 2025
- 400 Pages
Global
From €4357EUR$4,949USD£3,766GBP
- Report
- June 2025
- 400 Pages
Global
From €4357EUR$4,949USD£3,766GBP
- Report
- June 2025
- 400 Pages
Global
From €4357EUR$4,949USD£3,766GBP
- Report
- June 2025
- 400 Pages
Global
From €4357EUR$4,949USD£3,766GBP
- Report
- June 2025
- 400 Pages
Global
From €4357EUR$4,949USD£3,766GBP
- Report
- June 2025
- 400 Pages
Global
From €4357EUR$4,949USD£3,766GBP
- Report
- September 2025
- 150 Pages
Global
From €3918EUR$4,450USD£3,386GBP
- Report
- January 2026
- 128 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- January 2026
- 140 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- August 2025
- 154 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- June 2025
- 142 Pages
Global
From €3477EUR$3,950USD£3,005GBP
- Report
- September 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- September 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- June 2025
- 150 Pages
Global
From €4270EUR$4,850USD£3,690GBP
- Report
- February 2026
- 160 Pages
Global
From €2923EUR$3,320USD£2,526GBP
€3654EUR$4,150USD£3,158GBP
- Report
- February 2026
- 160 Pages
Global
From €2923EUR$3,320USD£2,526GBP
€3654EUR$4,150USD£3,158GBP
- Report
- January 2026
- 160 Pages
Global
From €2956EUR$3,358USD£2,555GBP
€3477EUR$3,950USD£3,005GBP
- Report
- January 2026
- 160 Pages
Global
From €2956EUR$3,358USD£2,555GBP
€3477EUR$3,950USD£3,005GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more